ArticlePharmacoEconomics2020

Updating the Cost Effectiveness of Oral Anticoagulants for Patients with Atrial Fibrillation Based on Varying Stroke and Bleed Risk Profiles.

Ching-Yu Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.